Literature DB >> 30871776

Transcriptional activation of ANO1 promotes gastric cancer progression.

Xiaoqing Zeng1, Duyi Pan1, Hao Wu2, Hao Chen3, Wei Yuan4, Ji Zhou1, Zhenbin Shen5, Shiyao Chen6.   

Abstract

The prognosis of gastric cancer (GC) remains poor due to local invasion and distal metastasis. The GC-related molecular mechanisms underlying invasion and metastasis are not well understood. In this study, we investigated the functional role of ANO1 in GC progression. We found that ANO1 is overexpressed in GC tissues and correlated with GC tumor-node-metastasis stage. Knockdown of ANO1 significantly inhibited GC cell migration and invasion in vitro, and loss of ANO1 resulted in inhibition of tumor metastasis in vivo. Mechanistically, SP1 increased ANO1 transcription, recruited MLL1 to the ANO1 promoter region, facilitated H3K4 trimethylation, and subsequently promoted ANO1 expression. Together, our findings provide a mechanistic assessment of ANO1 overexpression, which represents a GC progression-related molecule and a potentially valuable target for future research.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ANO1; Gastric cancer; MLL1; Progression; SP1

Mesh:

Substances:

Year:  2019        PMID: 30871776     DOI: 10.1016/j.bbrc.2019.03.001

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Role of ANO1 in tumors and tumor immunity.

Authors:  Haini Li; Zongxue Yu; Haiyan Wang; Ning Wang; Xueguo Sun; Shengmei Yang; Xu Hua; Zongtao Liu
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-26       Impact factor: 4.322

2.  DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancer.

Authors:  Kristina Jansen; Martina Kluth; Niclas C Blessin; Claudia Hube-Magg; Michael Neipp; Hamid Mofid; Hannes Lárusson; Thies Daniels; Christoph Isbert; Stephan Coerper; Daniel Ditterich; Holger Rupprecht; Albert Goetz; Christian Bernreuther; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Ronald Simon; Stefan Steurer; Eike Burandt; Daniel Perez; Jakob R Izbicki; Frank Jacobsen; Till S Clauditz; Andreas H Marx; Till Krech
Journal:  Histol Histopathol       Date:  2022-06-01       Impact factor: 2.130

Review 3.  Calcium-Activated Chloride Channel ANO1/TMEM16A: Regulation of Expression and Signaling.

Authors:  Nickolai O Dulin
Journal:  Front Physiol       Date:  2020-11-05       Impact factor: 4.566

Review 4.  DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Vincenzo Fiorentino; Patrizia Straccia; Pietro Tralongo; Teresa Musarra; Francesco Pierconti; Maurizio Martini; Guido Fadda; Esther Diana Rossi; Luigi Maria Larocca
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

Review 5.  The Ca2+-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?

Authors:  Yani Liu; Zongtao Liu; KeWei Wang
Journal:  Acta Pharm Sin B       Date:  2020-12-09       Impact factor: 11.413

6.  Activation of TMEM16A Ca2+-activated Cl- channels by ROCK1/moesin promotes breast cancer metastasis.

Authors:  Shuya Luo; Hui Wang; Lichuan Bai; Yiwen Chen; Si Chen; Kuan Gao; Huijie Wang; Shuwei Wu; Hanbin Song; Ke Ma; Mei Liu; Fan Yao; Yue Fang; Qinghuan Xiao
Journal:  J Adv Res       Date:  2021-03-17       Impact factor: 10.479

7.  A Pan-Cancer Study of KMT2 Family as Therapeutic Targets in Cancer.

Authors:  Jiamin Zhu; Zhili Liu; Xiao Liang; Lu Wang; Dan Wu; Weidong Mao; Dong Shen
Journal:  J Oncol       Date:  2022-01-11       Impact factor: 4.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.